Loading clinical trials...
Loading clinical trials...
Cannabidiol Pharmacotherapy for Co-occurring Opioid Use Disorder and Chronic Pain
Conditions
Interventions
400 mg Cannabidiol
800 mg Cannabidiol
+2 more
Locations
1
United States
Department of Veterans Affairs Hospital
West Haven, Connecticut, United States
Start Date
December 8, 2021
Primary Completion Date
August 31, 2026
Completion Date
August 31, 2026
Last Updated
April 14, 2026
NCT07538427
NCT04880096
NCT05885061
NCT05492825
NCT05942313
NCT07317271
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions